When changing opioid agents, recommendations generally include decreasing the dose of the new opioid by 25% to account for incomplete cross tolerance. This phenomenon occurs because opioid receptors of a patient may react differently to different opioids, therefore it cannot be assumed that the patient will have the same level of tolerance to a new opioid as the previous. However, if a patient is in severe pain, dosage is often not reduced